Skip to main content
Clinical Trials/NCT06394310
NCT06394310
Recruiting
Not Applicable

The Effectiveness of Dry Needling on Reducing Spasticity and Promoting Mobility and Balance in People With Multiple Sclerosis

University of Kansas Medical Center1 site in 1 country24 target enrollmentMay 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
University of Kansas Medical Center
Enrollment
24
Locations
1
Primary Endpoint
Spasticity
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

The investigators are doing this study to see if a treatment called dry needling improves muscle spasticity (muscle tightness) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those in acupuncture, to target some muscles, like calf muscles. It differs from traditional acupuncture as it focuses on treating or managing muscle spots, aiming to reduce muscle stiffness and pain. Dry needling may offer a minimally-invasive and medication-free approach to improve muscle spasticity. The investigators hope to see if dry needling also helps enhance balance and walking abilities. This might provide potential improvements inoverall mobility and balance.

Registry
clinicaltrials.gov
Start Date
May 1, 2024
End Date
August 1, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jacob J. Sosnoff, Ph.D.

Principal Investigator

University of Kansas Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 64 years
  • Clinical diagnosis of Multiple Sclerosis based on the McDonald Criteria
  • Spasticity in their lower legs
  • Patient Determined Disease Steps (PDDS) score of 5 or below

Exclusion Criteria

  • Inability to communicate effectively with study personnel
  • Needle phobia
  • Severe varicose veins
  • Presence of an active implanted device
  • Pregnancy
  • Any active cancer or history within 1 year
  • known or suspected infection at the site of needling or in the surrounding area
  • Presence of a fixed plantarflexion contracture at the ankle
  • Acute fracture of dislocation in the region (bilateral lower extremity)
  • Deep vein thrombosis or peripheral vascular disease

Outcomes

Primary Outcomes

Spasticity

Time Frame: 5 weeks

Spasticity will be assessed through the Modified Ashworth scale (Scored between 0 to 4, with higher scores show higher level of spasticity)

Study Sites (1)

Loading locations...

Similar Trials